Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth. (2023)
Attributed to:
BAG-1: A novel strategy for targeting the androgen receptor splice variants in castrate resistant prostate cancer.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41388-023-02604-x
PubMed Identifier: 36725887
Publication URI: http://europepmc.org/abstract/MED/36725887
Type: Journal Article/Review
Volume: 42
Parent Publication: Oncogene
Issue: 12
ISSN: 0950-9232